FutureFuel 10-Q Details $8.4M Q3 Loss, Cash Drop to $21.3M and LIFO Accounting Change
FF sits 50% above its 52-week low of $3.09.
Summary
FutureFuel's Q3 10-Q confirms the $8.4M loss on $104.7M revenue reported this morning, with cash down to $21.3M from $51.3M at year-end and a LIFO-to-weighted-average inventory change restating prior periods.
Key Events · Earnings and Guidance · FF
-
Q3 Revenue Quadruples, Loss Persists
Revenue rose 361% to $104.7M from $22.7M, but the company still posted an $8.4M net loss, or $0.19 per diluted share.
-
Cash Falls to $21.3M
Cash and equivalents dropped to $21.3M at September 30, 2026 from $51.3M at December 31, 2025, with $16.7M of capital expenditures and $11.5M used in operations.
-
Biodiesel Derivative Losses Hit Gross Profit
The biofuel segment recorded a $9.8M gross loss, including $8.7M of net derivative losses ($8.3M realized settlements) that management expects to economically offset in later periods.
-
LIFO to Weighted Average Cost Restatement
The inventory accounting change cut 2026 nine-month net loss to $17.6M from $26.3M under LIFO and reduced retained earnings by $8.7M versus the old method.
Analysis · FF · Industrial Applications And Services
The headline numbers match this morning's 8-K — $104.7M of Q3 revenue against an $8.4M net loss — but the full 10-Q shows what sits behind them. Cash fell to $21.3M from $51.3M at year-end 2025 as receivables and inventory absorbed working capital and $16.7M went into capital spending, so the balance sheet is meaningfully thinner even as revenue quadrupled. The biodiesel segment lost $9.8M gross in the quarter, driven largely by $8.7M of net derivative losses (including $8.3M of realized settlements) that management says are timing items expected to reverse when the physical inventory is delivered. The company also switched inventory accounting from LIFO to weighted average cost, which restates prior periods and makes the 2026 nine-month loss $17.6M versus $26.3M under the old method — a comparability change, not a cash event. No debt is drawn on the $35M revolver, and a new five-year custom chemical supply contract signed October 3 supports the chemical segment's growth.
How filings like this one have moved
In the 30 days to Nov 10, 2026, 36.4% of the 3168 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, FF was trading at $4.65 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $222.4M. The 52-week trading range was $3.09 to $6.99. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.